Increased hepatic expression of nitric oxide synthase type II in cirrhotic rats

Table 4 Effects of tetrandrine on hemodynamics in cirrhotic rats (mean ± SD)

Stage	Index	Tetrandrine	Cirrhosis	Negative control
		(n = 8)	(n = 8)	(n = 8)
Earlier period	PVF	18.37 ± 1.83	21.25 ± 1.76	16.50 ± 1.73
	PVP	1.35 ± 0.25b	1.67 ± 0.21	1.18 ± 0.13
	ICVP	0.31 ± 0.04	0.32 ± 0.04	0.31 ± 0.04
	PVR	5.73 ± 0.88	6.38 ± 1.12	5.81 ± 1.04
Metaphase	PVF	14.50 ± 1.61a	20.35 ± 1.07	17.75 ± 1.37
	PVP	1.44 ± 0.13b	1.72 ± 0.69	1.30 ± 0.21
	ICVP	0.32 ± 0.04	0.31 ± 0.04	0.32 ± 0.04
	PVR	7.98 ± 1.68	9.56 ± 1.29	5.53 ± 0.67
Late period	PVF	15.85 ± 1.23	17.57 ± 1.93	15.42 ± 1.27
	PVP	1.45 ± 0.24b	1.67 ± 0.23	1.37 ± 0.10
	ICVP	0.31 ± 0.04	0.32 ± 0.04	0.32 ± 0.04
	PVR	7.44 ± 1.08	8.01 ± 0.79	6.76 ± 0.34

^aP < 0.05,

^bP < 0.01 vs cirrhosis.